| dc.contributor.author | Askin, L | |
| dc.contributor.author | Askin, HS | |
| dc.contributor.author | Abus, S | |
| dc.contributor.author | Hidayet, S | |
| dc.date.accessioned | 2023-01-02T08:49:25Z | |
| dc.date.available | 2023-01-02T08:49:25Z | |
| dc.date.issued | 2022 | |
| dc.identifier.uri | http://hdl.handle.net/11616/86603 | |
| dc.description.abstract | Increased vascular oxidative stress stimulates the secretion of adipokines from adipocytes. Many clinical studies have demonstrated that plasma adipsin levels are successful in predicting ischemic events. Increased adipsin levels are closely related to all-cause death and morbidity. Therefore, adipsin may be a new biomarker for atherosclerosis. In this review, we aimed to emphasize the association of adipsin with cardiovascular diseases (CVDs) and its beneficial role in the therapeutic field of CVDs. | |
| dc.source | COR ET VASA | |
| dc.title | Adipsin as a novel prognostic biomarker for cardiovascular diseases |
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||